Last reviewed · How we verify

NCT03118583

Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers

Completed NA Last updated 15 May 2018
What this trial tests

NA trial testing 300 mg/day of dietary supplement containing carrageenan in Healthy Volunteers in 12 participants. Completed in 31 January 2018.

Timeline
15 March 2017
Primary endpoint
31 December 2017
31 January 2018

Quick facts

Lead sponsorMidwest Center for Metabolic and Cardiovascular Research
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment12
Start date15 March 2017
Primary completion31 December 2017
Estimated completion31 January 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Midwest Center for Metabolic and Cardiovascular Research

Who can join

Adults 25 to 69, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to assess the effects of a dietary supplement on fasting lipoprotein lipids and a marker of inflammation in men and women with levels of low-density lipoprotein cholesterol above desirable levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

Other Midwest Center for Metabolic and Cardiovascular Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03118583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing